Clinical Endoscopy

  • 제55권6호
  • /
  • Pages.703-725
  • /
  • 2022
  • /
  • 2234-2400(pISSN)
  • /
  • 2234-2443(eISSN)
대한소화기내시경학회 (The Korean Society of Gastrointestinal Endoscopy)
권호 표지
DOI QR코드

DOI QR Code

Korean guidelines for postpolypectomy colonoscopic surveillance: 2022 revised edition

  • Su Young Kim (Department of Gastroenterology, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine) ;
  • Min Seob Kwak (Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine) ;
  • Soon Man Yoon (Department of Gastroenterology, Chungbuk National University Hospital, Chungbuk National University College of Medicine) ;
  • Yunho Jung (Department of Internal Medicine, Soonchunhyang University College of Medicine) ;
  • Jong Wook Kim (Department of Gastroenterology, Inje University Ilsan Paik Hospital) ;
  • Sun-Jin Boo (Department of Internal Medicine, Jeju National University School of Medicine) ;
  • Eun Hye Oh (Department of Gastroenterology, Hanyang University Guri Hospital, Hanyang University College of Medicine) ;
  • Seong Ran Jeon (Digestive Disease Center, Institute for Digestive Research, Soonchunhyang University College of Medicine) ;
  • Seung-Joo Nam (Department of Internal Medicine, Kangwon National University School of Medicine) ;
  • Seon-Young Park (Department of Internal Medicine, Chonnam National University Medical School) ;
  • Soo-Kyung Park (Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Jaeyoung Chun (Department of Gastroenterology, Gangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Dong Hoon Baek (Department of Internal Medicine, Pusan National University School of Medicine) ;
  • Mi-Young Choi (National Evidence-Based Healthcare Collaborating Agency) ;
  • Suyeon Park (Department of biostatistics, Soonchunhyang University College of Medicine) ;
  • Jeong-Sik Byeon (Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Hyung Kil Kim (Department of Gastroenterology, Inha University Hospital, Inha University School of Medicine) ;
  • Joo Young Cho (Department of Gastroenterology, CHA Gangnam Medical Center) ;
  • Moon Sung Lee (Digestive Disease Center, Institute for Digestive Research, Soonchunhyang University College of Medicine) ;
  • Oh Young Lee (Department of Internal Medicine, Hanyang University School of Medicine) ;
  • Korean Society of Gastrointestinal Endoscopy (Korean Society of Gastrointestinal Endoscopy) ;
  • Korean Society of Gastroenterology (Korean Society of Gastroenterology) ;
  • Korean Association for the Study of Intestinal Diseases (Korean Association for the Study of Intestinal Diseases)
  • 투고 : 2022.04.26
  • 심사 : 2022.06.22
  • 발행 : 2022.11.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Colonoscopic polypectomy is effective in decreasing the incidence and mortality of colorectal cancer (CRC). Premalignant polyps discovered during colonoscopy are associated with the risk of metachronous advanced neoplasia. Postpolypectomy surveillance is the most important method for the management of advanced metachronous neoplasia. A more efficient and evidence-based guideline for postpolypectomy surveillance is required because of limited medical resources and concerns regarding colonoscopy complications. In these consensus guidelines, an analytic approach was used to address all reliable evidence to interpret the predictors of CRC or advanced neoplasia during surveillance colonoscopy. The key recommendations state that the high-risk findings for metachronous CRC following polypectomy are as follows: (1) adenoma ≥10 mm in size; (2) 3 to 5 (or more) adenomas; (3) tubulovillous or villous adenoma; (4) adenoma containing high-grade dysplasia; (5) traditional serrated adenoma; (6) sessile serrated lesion (SSL) containing any grade of dysplasia; (7) serrated polyp of at least 10 mm in size; and (8) 3 to 5 (or more) SSLs. More studies are needed to fully comprehend the patients most likely to benefit from surveillance colonoscopy and the ideal surveillance interval to prevent metachronous CRC.

키워드

과제정보

We would like to express our gratitude to Chang Kyun Lee, Dong Il Park, Jae Myung Cha, Young-Eun Joo, Hyun-Soo Kim, Dong Soo Han, Dong-Kyung Chang, and Tae Il Kim, who provided invaluable advice for the development of the Korean guidelines for postpolypectomy colonoscopic surveillance.

참고문헌

  1. Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin 2020;70:145-164.
  2. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy: the National Polyp Study Workgroup. N Engl J Med 1993;329:1977-1981.
  3. Zauber AG, Winawer SJ, O'Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012;366:687-696.
  4. Robertson DJ, Greenberg ER, Beach M, et al. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology 2005;129:34-41.
  5. Cottet V, Jooste V, Fournel I, et al. Long-term risk of colorectal cancer after adenoma removal: a population-based cohort study. Gut 2012;61:1180-1186.
  6. Cha JM, Kwak MS, Kim HS, et al. Real-world national colonoscopy volume in Korea: a nationwide population-based study over 12 years. Gut Liver 2020;14:338-346.
  7. Rapuri S, Spencer J, Eckels D. Importance of postpolypectomy surveillance and postpolypectomy compliance to follow-up screening: review of literature. Int J Colorectal Dis 2008;23:453-459.
  8. Kim SY, Kim HS, Park HJ. Adverse events related to colonoscopy: global trends and future challenges. World J Gastroenterol 2019;25:190-204.
  9. Hong SN, Yang DH, Kim YH, et al. Korean guidelines for post-polypectomy colonoscopic surveillance. Korean J Gastroenterol 2012;59:99-117.
  10. Gupta S, Lieberman D, Anderson JC, et al. Recommendations for follow-up after colonoscopy and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2020;158:1131-1153.
  11. Hassan C, Antonelli G, Dumonceau JM, et al. Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline: update 2020. Endoscopy 2020;52:687-700.
  12. Rutter MD, East J, Rees CJ, et al. British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines. Gut 2020;69:201-223.
  13. Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 2010;182:E839-E842.
  14. Lowe G, Twaddle S. The Scottish Intercollegiate Guidelines Network (SIGN): an update. Scott Med J 2005;50:51-52.
  15. Schunemann HJ, Wiercioch W, Etxeandia I, et al. Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise. CMAJ 2014;186:E123-E142.
  16. Mustafa RA, Santesso N, Brozek J, et al. The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses. J Clin Epidemiol 2013;66:736-742.
  17. Zhang Y, Akl EA, Schunemann HJ. Using systematic reviews in guideline development: the GRADE approach. Res Synth Methods 2019;10:312-329.
  18. Kaminski MF, Thomas-Gibson S, Bugajski M, et al. Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy 2017;49:378-397.
  19. Min JK, Cha JM, Cho YK, et al. Revision of quality indicators for the Endoscopy Quality Improvement Program of the National Cancer Screening Program in Korea. Clin Endosc 2018;51:239-252.
  20. Rex DK, Schoenfeld PS, Cohen J, et al. Quality indicators for colonoscopy. Gastrointest Endosc 2015;81:31-53.
  21. Atkin W, Wooldrage K, Brenner A, et al. Adenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study. Lancet Oncol 2017;18:823-834.
  22. Wieszczy P, Kaminski MF, Franczyk R, et al. Colorectal cancer incidence and mortality after removal of adenomas during screening colonoscopies. Gastroenterology 2020;158:875-883.
  23. Cross AJ, Robbins EC, Pack K, et al. Long-term colorectal cancer incidence after adenoma removal and the effects of surveillance on incidence: a multicentre, retrospective, cohort study. Gut 2020;69:1645-1658.
  24. He X, Hang D, Wu K, et al. Long-term risk of colorectal cancer after removal of conventional adenomas and serrated polyps. Gastroenterology 2020;158:852-861.
  25. Tollivoro TA, Jensen CD, Marks AR, et al. Index colonoscopy-related risk factors for postcolonoscopy colorectal cancers. Gastrointest Endosc 2019;89:168-176.
  26. Anderson JC, Rex DK, Robinson C, et al. Association of small versus diminutive adenomas and the risk for metachronous advanced adenomas: data from the New Hampshire Colonoscopy Registry. Gastrointest Endosc 2019;90:495-501.
  27. Hartstein JD, Vemulapalli KC, Rex DK. The predictive value of small versus diminutive adenomas for subsequent advanced neoplasia. Gastrointest Endosc 2020;91:614-621.
  28. Click B, Pinsky PF, Hickey T, et al. Association of colonoscopy adenoma findings with long-term colorectal cancer incidence. JAMA 2018;319:2021-2031.
  29. Vemulapalli KC, Rex DK. Risk of advanced lesions at first follow-up colonoscopy in high-risk groups as defined by the United Kingdom post-polypectomy surveillance guideline: data from a single U.S. center. Gastrointest Endosc 2014;80:299-306.
  30. Cubiella J, Carballo F, Portillo I, et al. Incidence of advanced neoplasia during surveillance in high- and intermediate-risk groups of the European colorectal cancer screening guidelines. Endoscopy 2016;48:995-1002.
  31. Laish I, Seregeev I, Naftali T, et al. Surveillance after positive colonoscopy based on adenoma characteristics. Dig Liver Dis 2017;49:1115-1120.
  32. Kim JY, Kim TJ, Baek SY, et al. Risk of metachronous advanced neoplasia in patients with multiple diminutive adenomas. Am J Gastroenterol 2018;113:1855-1861.
  33. Moon CM, Jung SA, Eun CS, et al. The effect of small or diminutive adenomas at baseline colonoscopy on the risk of developing metachronous advanced colorectal neoplasia: KASID multicenter study. Dig Liver Dis 2018;50:847-852.
  34. Park SK, Yang HJ, Jung YS, et al. Risk of advanced colorectal neoplasm by the proposed combined United States and United Kingdom risk stratification guidelines. Gastrointest Endosc 2018;87:800-808.
  35. Kim NH, Jung YS, Lee MY, et al. Risk of developing metachronous advanced colorectal neoplasia after polypectomy in patients with multiple diminutive or small adenomas. Am J Gastroenterol 2019;114:1657-1664.
  36. Lieberman D, Sullivan BA, Hauser ER, et al. Baseline colonoscopy findings associated with 10-year outcomes in a screening cohort undergoing colonoscopy surveillance. Gastroenterology 2020;158:862-874.
  37. Pinsky PF, Schoen RE. Contribution of surveillance colonoscopy to colorectal cancer prevention. Clin Gastroenterol Hepatol 2020;18:2937-2944.
  38. Shono T, Oyama S, Oda Y, et al. Risk stratification of advanced colorectal neoplasia after baseline colonoscopy: cohort study of 17 Japanese community practices. Dig Endosc 2020;32:106-113.
  39. Park SK, Hwang SW, Kim KO, et al. Risk of advanced colorectal neoplasm in patients with more than 10 adenomas on index colonoscopy: a Korean Association for the Study of Intestinal Diseases (KASID) study. J Gastroenterol Hepatol 2017;32:803-808.
  40. Grover S, Kastrinos F, Steyerberg EW, et al. Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas. JAMA 2012;308:485-492.
  41. Syngal S, Brand RE, Church JM, et al. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 2015;110:223-262.
  42. Provenzale D, Gupta S, Ahnen DJ, et al. Genetic/familial high-risk assessment: colorectal version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2016;14:1010-1030.
  43. Myers DJ, Arora K. Villous adenoma [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 [cited 2022 Apr 26]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470272/.
  44. Fairley KJ, Li J, Komar M, et al. Predicting the risk of recurrent adenoma and incident colorectal cancer based on findings of the baseline colonoscopy. Clin Transl Gastroenterol 2014;5:e64.
  45. van Heijningen EM, Lansdorp-Vogelaar I, Kuipers EJ, et al. Features of adenoma and colonoscopy associated with recurrent colorectal neoplasia based on a large community-based study. Gastroenterology 2013;144:1410-1418.
  46. Song M, Emilsson L, Bozorg SR, et al. Risk of colorectal cancer incidence and mortality after polypectomy: a Swedish record-linkage study. Lancet Gastroenterol Hepatol 2020;5:537-547.
  47. Saini SD, Kim HM, Schoenfeld P. Incidence of advanced adenomas at surveillance colonoscopy in patients with a personal history of colon adenomas: a meta-analysis and systematic review. Gastrointest Endosc 2006;64:614-626.
  48. Mahajan D, Downs-Kelly E, Liu X, et al. Reproducibility of the villous component and high-grade dysplasia in colorectal adenomas <1 cm: implications for endoscopic surveillance. Am J Surg Pathol 2013;37:427-433.
  49. Foss FA, Milkins S, McGregor AH. Inter-observer variability in the histological assessment of colorectal polyps detected through the NHS Bowel Cancer Screening Programme. Histopathology 2012;61:47-52.
  50. Amersi F, Agustin M, Ko CY. Colorectal cancer: epidemiology, risk factors, and health services. Clin Colon Rectal Surg 2005;18:133-140.
  51. Macaron C, Vu HT, Lopez R, et al. Risk of metachronous polyps in individuals with serrated polyps. Dis Colon Rectum 2015;58:762-768.
  52. Erichsen R, Baron JA, Hamilton-Dutoit SJ, et al. Increased risk of colorectal cancer development among patients with serrated polyps. Gastroenterology 2016;150:895-902.
  53. Holme O, Bretthauer M, Eide TJ, et al. Long-term risk of colorectal cancer in individuals with serrated polyps. Gut 2015;64:929-936.
  54. Lu FI, van Niekerk de W, Owen D, et al. Longitudinal outcome study of sessile serrated adenomas of the colorectum: an increased risk for subsequent right-sided colorectal carcinoma. Am J Surg Pathol 2010;34:927-934.
  55. Symonds E, Anwar S, Young G, et al. Sessile serrated polyps with synchronous conventional adenomas increase risk of future advanced neoplasia. Dig Dis Sci 2019;64:1680-1685.
  56. Anderson JC, Butterly LF, Robinson CM, et al. Risk of metachronous high-risk adenomas and large serrated polyps in individuals with serrated polyps on index colonoscopy: data from the New Hampshire Colonoscopy Registry. Gastroenterology 2018;154:117-127.
  57. Teriaky A, Driman DK, Chande N. Outcomes of a 5-year follow-up of patients with sessile serrated adenomas. Scand J Gastroenterol 2012;47:178-183.
  58. Schreiner MA, Weiss DG, Lieberman DA. Proximal and large hyperplastic and nondysplastic serrated polyps detected by colonoscopy are associated with neoplasia. Gastroenterology 2010;139:1497-1502.
  59. Lazarus R, Junttila OE, Karttunen TJ, et al. The risk of metachronous neoplasia in patients with serrated adenoma. Am J Clin Pathol 2005;123:349-359.
  60. Yoon JY, Kim HT, Hong SP, et al. High-risk metachronous polyps are more frequent in patients with traditional serrated adenomas than in patients with conventional adenomas: a multicenter prospective study. Gastrointest Endosc 2015;82:1087-1093.
  61. Payne SR, Church TR, Wandell M, et al. Endoscopic detection of proximal serrated lesions and pathologic identification of sessile serrated adenomas/polyps vary on the basis of center. Clin Gastroenterol Hepatol 2014;12:1119-1126.
  62. Ensari A, Bilezikci B, Carneiro F, et al. Serrated polyps of the colon: how reproducible is their classification? Virchows Arch 2012;461:495-504.
  63. Khalid O, Radaideh S, Cummings OW, et al. Reinterpretation of histology of proximal colon polyps called hyperplastic in 2001. World J Gastroenterol 2009;15:3767-3770.
  64. Wong NA, Hunt LP, Novelli MR, et al. Observer agreement in the diagnosis of serrated polyps of the large bowel. Histopathology 2009;55:63-66.
  65. Bustamante-Balen M, Bernet L, Cano R, et al. Assessing the reproducibility of the microscopic diagnosis of sessile serrated adenoma of the colon. Rev Esp Enferm Dig 2009;101:258-264.
  66. Farris AB, Misdraji J, Srivastava A, et al. Sessile serrated adenoma: challenging discrimination from other serrated colonic polyps. Am J Surg Pathol 2008;32:30-35.
  67. Hiraoka S, Kato J, Fujiki S, et al. The presence of large serrated polyps increases risk for colorectal cancer. Gastroenterology 2010;139:1503-1510.
  68. Lash RH, Genta RM, Schuler CM. Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients. J Clin Pathol 2010;63:681-686.
  69. Imperiale TF, Glowinski EA, Lin-Cooper C, et al. Five-year risk of colorectal neoplasia after negative screening colonoscopy. N Engl J Med 2008;359:1218-1224.
  70. Lieberman DA, Rex DK, Winawer SJ, et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2012;143:844-857.
  71. Lim HM, Kim ER, Kim JY, et al. Association between non-diminutive hyperplastic polyps and synchronous advanced colorectal neoplasms. Digestion 2011;83:54-59.
  72. Pereyra L, Zamora R, Gomez EJ, et al. Risk of metachronous advanced neoplastic lesions in patients with sporadic sessile serrated adenomas undergoing colonoscopic surveillance. Am J Gastroenterol 2016;111:871-878.
  73. Burnett-Hartman AN, Chubak J, Hua X, et al. The association between colorectal sessile serrated adenomas/polyps and subsequent advanced colorectal neoplasia. Cancer Causes Control 2019;30:979-987.
  74. Pohl H, Srivastava A, Bensen SP, et al. Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology 2013;144:74-80.
  75. Belderbos TD, Leenders M, Moons LM, et al. Local recurrence after endoscopic mucosal resection of nonpedunculated colorectal lesions: systematic review and meta-analysis. Endoscopy 2014;46:388-402.
  76. Pellise M, Burgess NG, Tutticci N, et al. Endoscopic mucosal resection for large serrated lesions in comparison with adenomas: a prospective multicentre study of 2000 lesions. Gut 2017;66:644-653. 
  77. Tate DJ, Desomer L, Klein A, et al. Adenoma recurrence after piecemeal colonic EMR is predictable: the Sydney EMR recurrence tool. Gastrointest Endosc 2017;85:647-656.
  78. Komeda Y, Watanabe T, Sakurai T, et al. Risk factors for local recurrence and appropriate surveillance interval after endoscopic resection. World J Gastroenterol 2019;25:1502-1512.
  79. Klein A, Tate DJ, Jayasekeran V, et al. Thermal ablation of mucosal defect margins reduces adenoma recurrence after colonic endoscopic mucosal resection. Gastroenterology 2019;156:604-613.
  80. Jang HW, Park SJ, Hong SP, et al. Risk factors for recurrent high-risk polyps after the removal of high-risk polyps at initial colonoscopy. Yonsei Med J 2015;56:1559-1565.
  81. Park SK, Kim NH, Jung YS, et al. Risk of developing advanced colorectal neoplasia after removing high-risk adenoma detected at index colonoscopy in young patients: a KASID study. J Gastroenterol Hepatol 2016;31:138-144.
  82. Martinez ME, Baron JA, Lieberman DA, et al. A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology 2009;136:832-841.
  83. Jacobs ET, Gupta S, Baron JA, et al. Family history of colorectal cancer in first-degree relatives and metachronous colorectal adenoma. Am J Gastroenterol 2018;113:899-905.
  84. Lieberman DA, Weiss DG, Harford WV, et al. Five-year colon surveillance after screening colonoscopy. Gastroenterology 2007;133:1077-1085.
  85. Chung SJ, Kim YS, Yang SY, et al. Five-year risk for advanced colorectal neoplasia after initial colonoscopy according to the baseline risk stratification: a prospective study in 2452 asymptomatic Koreans. Gut 2011;60:1537-1543.
  86. Lee JK, Jensen CD, Levin TR, et al. Long-term risk of colorectal cancer and related death after adenoma removal in a large, community-based population. Gastroenterology 2020;158:884-894.
  87. Loberg M, Kalager M, Holme O, et al. Long-term colorectal-cancer mortality after adenoma removal. N Engl J Med 2014;371:799-807.
  88. Hassan C, Gimeno-Garcia A, Kalager M, et al. Systematic review with meta-analysis: the incidence of advanced neoplasia after polypectomy in patients with and without low-risk adenomas. Aliment Pharmacol Ther 2014;39:905-912.
  89. Dube C, Yakubu M, McCurdy BR, et al. Risk of advanced adenoma, colorectal cancer, and colorectal cancer mortality in people with low-risk adenomas at baseline colonoscopy: a systematic review and meta-analysis. Am J Gastroenterol 2017;112:1790-1801.
  90. Atkin W, Brenner A, Martin J, et al. The clinical effectiveness of different surveillance strategies to prevent colorectal cancer in people with intermediate-grade colorectal adenomas: a retrospective cohort analysis, and psychological and economic evaluations. Health Technol Assess 2017;21:1-536.
  91. Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 1992;326:658-662.
  92. Noshirwani KC, van Stolk RU, Rybicki LA, et al. Adenoma size and number are predictive of adenoma recurrence: implications for surveillance colonoscopy. Gastrointest Endosc 2000;51(4 Pt 1):433-437.
  93. Jung YS, Park DI, Kim WH, et al. Risk of advanced colorectal neoplasia according to the number of high-risk findings at index colonoscopy: a Korean Association for the Study of Intestinal Disease (KASID) Study. Dig Dis Sci 2016;61:1661-1668.
  94. Zhao S, Wang S, Pan P, et al. Magnitude, risk factors, and factors associated with adenoma miss rate of tandem colonoscopy: a systematic review and meta-analysis. Gastroenterology 2019;156:1661-1674.
  95. Mankaney G, Rouphael C, Burke CA. Serrated polyposis syndrome. Clin Gastroenterol Hepatol 2020;18:777-779.
  96. Rex DK, Ahnen DJ, Baron JA, et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 2012;107:1315-1329.
  97. Tan YY, Tay GS, Wong YJ, et al. Clinical features and predictors of dysplasia in proximal sessile serrated lesions. Clin Endosc 2021;54:578-588.
  98. Tran AH, Man Ngor EW, Wu BU. Surveillance colonoscopy in elderly patients: a retrospective cohort study. JAMA Intern Med 2014;174:1675-1682.
  99. Gutta A, Gromski MA. Endoscopic management of post-polypectomy bleeding. Clin Endosc 2020;53:302-310.